FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,117 letters match. Newest first.
-
DrugsEverlaan Organics, Inc. dba Maple Organics
FDA warns Maple Organics over OTC drug CGMP failures, unapproved new drugs, and misbranding.
High risk -
DevicesLes Encres LLC
FDA warns Les Encres that its PDO surgical suture threads were promoted for unapproved cosmetic uses and had quality system violations.
High risk -
FoodChaohu Daxin Foodstuffs Co., Ltd.
FDA warns Chaohu Daxin Foodstuffs that its ready-to-eat cooked crawfish from China is adulterated due to an inadequate seafood HACCP plan and poor sanitation.
High risk -
DrugsABBE Laboratories, Inc.
FDA warns ABBE Laboratories over manufacturing failures for over-the-counter topical drugs, including ingredient testing.
High risk -
DevicesSpectra Therapy, LLC
FDA warns Spectra Therapy over LASERwrap infrared lamp device quality-system violations and unapproved disease-treatment claims.
High risk -
DrugsGussyup LLC dba Private Label Grooming
FDA found Gussyup LLC, a Henderson, Nevada OTC drug maker, lacking quality oversight and ingredient identity testing; company stopped drug production.
High risk -
DrugsOasis Medical, Inc.
FDA cites Oasis Medical for current good manufacturing practice violations in sterile ophthalmic drugs, including particulate contamination and unresolved sterility failures.
High risk -
DevicesMectronic Medicale S.R.L.
FDA warns Mectronic Medicale over quality system failures and uncleared marketing of therapeutic RF/laser devices.
High risk -
DevicesVisgeneer, Inc
FDA warns Taiwan maker Visgeneer over design validation and complaint handling failures for blood glucose and uric acid meters.
High risk -
DrugsShiva Analyticals Private Limited
FDA warned Shiva Analyticals, an Indian contract drug testing lab, that inadequate OOS investigations and data integrity failures adulterated tested drugs.
High risk -
DevicesOnkos Surgical, Inc.
FDA warns Onkos Surgical over ELEOS implant system cleaning, corrective-action, risk, sampling, and removal-reporting failures.
High risk -
DrugsKabana Skin Care LLC
Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.
High risk -
DrugsMacsen Drugs
FDA cites Macsen Drugs for releasing fire-exposed APIs and inadequate stability data at India plant.
High risk -
DevicesLeltek Inc.
FDA warns Leltek over quality-system failures for LU700 and LK128 ultrasound systems, including corrective actions, complaints, records, and adverse-event reporting.
Medium -
DrugsGlenmark Pharmaceuticals Limited
FDA warns Glenmark over unresolved dissolution failures and inadequate investigations at its Pithampur, India drug plant.
High risk -
DrugsMedical Chemical Corporation
FDA warned Medical Chemical Corp over manufacturing violations, unapproved Tincture Green Soap, and improper drug listing.
High risk -
BiologicsO3UV, LLC
FDA warns O3UV that its Champion and EBOO ozone/UV blood devices are unapproved, misbranded, and made without required quality controls.
High risk -
DrugsNature’s Fusions LLC
FDA cited Nature's Fusions for over-the-counter hand sanitizer manufacturing with inadequate stability, component and finished-product testing, and water controls.
High risk -
DrugsDaewoo Pharmaceutical Co., Ltd.
FDA warns Daewoo Pharmaceutical over CGMP (manufacturing quality rules) failures at Busan plant; company suspended production.
High risk -
FoodThang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ
FDA says Thang Botanicals' 7OHMZ kratom shot, tablets, and gummies contain unsafe 7-OH and are adulterated.
High risk -
FoodMy Smoke Wholesale
My Smoke Wholesale's 777 Jackpot Alkaloids tablets are adulterated dietary supplements because 7-OH lacks adequate safety information.
High risk -
DrugsLibby Laboratories, Inc.
FDA warned Libby Laboratories of Berkeley, California, that its drug manufacturing violated CGMP, including releasing a hospital antiseptic without microbial testing.
High risk -
DrugsXtreme Tools International, Inc.
FDA warned Xtreme Tools International after an inspection found manufacturing-rule failures for OTC topical drugs, including missing ingredient and batch testing.
High risk -
AnimalLystn LLC dba Answers Pet Food
FDA warned Answers Pet Food that its raw pet food contained Salmonella and Listeria and was made under insanitary conditions.
High risk -
DrugsDynamic Blending Specialists, Inc.
FDA cited Dynamic Blending Specialists for manufacturing failures in OTC drugs and an unapproved, misbranded oral antiseptic.
High risk -
AnimalJ.D. Heiskell Holdings LLC
J.D. Heiskell's Idaho feed mill made calf feed with too much monensin linked to calf deaths, then mixed the recalled feed into non-medicated feed.
High risk -
DrugsExela Pharma Sciences, LLC
Exela Pharma Sciences failed CGMP (current good manufacturing practice) for sterile injectable drugs, including invalidated sterility-media tests and inaccurate microbiology records.
High risk -
DrugsHealwell Homeo Private Limited
FDA warns Healwell Homeo over pest-infested drug storage and manufacturing violations.
High risk -
DrugsStaska Pharmaceuticals, Inc.
FDA warns Staska Pharmaceuticals, a Nebraska outsourcing facility, that sterile compounded drugs had contamination risks and labeling problems.
High risk -
DrugsPushclean Technology Plastik Sanayi Ve Ticaret Ltd. Sirketi
FDA warns Turkish OTC drug wipe maker Pushclean over missing finished-product and component testing.
High risk -
FoodMarin Baking LLC
FDA warned Marin Baking that its ready-to-eat bread was made under insanitary conditions with rodent and insect filth.
High risk -
DevicesAju Pharm Co., Ltd.
FDA warns Aju Pharm over unvalidated Fixone suture anchors and multiple quality-system failures.
High risk -
FoodM.O.M. Enterprises, LLC
FDA warned M.O.M. Enterprises over adulterated, misbranded baby supplements and unapproved-drug claims for Gripe Water.
High risk -
FoodRevolution Foods, PBC
FDA says Revolution Foods' ready-to-eat school and senior meals lack allergen labels and pathogen controls.
High risk -
FoodYongdae Hwangtae Union Corp Daeryung
FDA found Yongdae Hwangtae Union's raw ready-to-eat dried pollack exposed outdoors and its seafood hazard-control plan inadequate for pathogens and allergens.
High risk -
DrugsKenil Healthcare Private Limited
FDA warns Kenil Healthcare over adulterated drugs from India due to cleaning, packaging, and quality failures.
High risk -
DevicesReset Technology Corporation
FDA warns Reset Technology about missing validation and complaint handling for ResetSmile dental devices.
High risk -
DrugsZhejiang Huahai Pharmaceutical Co., Ltd.
FDA warns Zhejiang Huahai Pharmaceutical over CGMP violations including dirty equipment, aseptic-area tape, and data integrity issues.
High risk -
DrugsHorizon Tool Inc.
FDA warns Horizon Tool over manufacturing-rule violations for AllShield E2 Sanitizing Hand Soap.
High risk -
DrugsLaboratoire Druide Inc.
FDA warned Laboratoire Druide that its OTC drugs are adulterated because of inadequate glycerin identity testing, system validation and cleaning.
High risk -
DrugsAmish Origins Management, LLC
FDA warned Amish Origins over manufacturing quality failures and unapproved or misbranded OTC pain relief and lip balm products.
High risk -
FoodOne Roof LLC
FDA warned One Roof LLC of allergen, pathogen and manufacturing-rule violations in its Baltimore ready-to-eat bakery products.
High risk -
DrugsCTK OTC Laboratories LLC formerly FMK LABS, Inc.
CTK OTC Laboratories, formerly FMK Labs, failed to investigate out-of-spec results and validate processes for OTC drugs, including sunscreens.
High risk -
DrugsEvi Labs LLC
FDA warns Evi Labs over OTC drug manufacturing failures, including an antiperspirant lot above the aluminum chlorohydrate limit.
High risk -
DrugsZhejiang Easyclean Daily Chemical Co., Ltd
FDA warned Zhejiang Easyclean Daily Chemical that its OTC drugs lacked required testing and manufacturing controls.
High risk -
DevicesDFI Co., Ltd.
DFI Co., Ltd. of Gimhae, Korea, made CYBOW 11 urinalysis reagent strips under conditions FDA calls adulterated — complaint, nonconforming product, labeling and MDR failures.
High risk -
DrugsRechon Life Science AB
FDA warns Swedish sterile drugmaker Rechon Life Science over aseptic technique, weak investigations, cleaning and facility problems.
High risk -
FoodAnti L’Age
FDA warned Anti L'Age over dietary supplements made without required manufacturing standards, records, quality controls, and proper labeling.
Medium -
FoodLa Milagrosa 1 LLC
FDA says La Milagrosa 1 LLC made ready-to-eat Latin-style cheese without a food safety plan and under insanitary conditions.
High risk -
FoodMother Earth Minerals, Inc.
FDA warns Mother Earth Minerals that its Calcium, Magnesium and Silver are unapproved drugs with disease claims and lack quality controls.
High risk